Decoding non-random mutational signatures at Cas9 targeted sites-Reference-Cited by-同舟云学术

Decoding non-random mutational signatures at Cas9 targeted sites

Published:2018-07-19 Issue:16 Volume:46 Page:8417-8434
ISSN:0305-1048
Container-title:Nucleic Acids Research
language:en
Short-container-title:

Author:

Taheri-Ghahfarokhi Amir¹^ORCID,Taylor Benjamin J M²^ORCID,Nitsch Roberto¹³,Lundin Anders¹,Cavallo Anna-Lina¹,Madeyski-Bengtson Katja¹,Karlsson Fredrik⁴,Clausen Maryam¹,Hicks Ryan¹,Mayr Lorenz M¹⁵,Bohlooly-Y Mohammad¹,Maresca Marcello¹

Affiliation:

1. Translational Genomics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden

2. Discovery Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, UK

3. Advanced Medicines Safety, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden

4. Quantitative Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden

5. GE Healthcare Life Sciences, The Grove Centre, White Lion Road, Amersham HP7 9LL, UK

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/46/16/8417/25802634/gky653.pdf

Reference81 articles.

1. A putative viral defence mechanism in archaeal cells;Lillestol;Archaea,2006

2. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action;Makarova;Biol. Direct,2006

3. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea;Marraffini;Nat. Rev. Genet.,2010

4. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity;Jinek;Science,2012

5. RNA-guided human genome engineering via Cas9;Mali;Science,2013

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells;Nature Communications;2024-01-02

2. DNA polymerases in precise and predictable CRISPR/Cas9-mediated chromosomal rearrangements;BMC Biology;2023-12-08

3. BRCA1/2 reversion mutations in a pan‐cancer cohort;Cancer Science;2023-12

4. Recent advances and challenges of the use of the CRISPR/Cas system as a non-nucleic acid molecular diagnostic;Heliyon;2023-12

5. A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo;Nature Communications;2023-09-06